Moors & Cabot, Inc. Gsk PLC Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$42.05 - $47.77 $16,273 - $18,486	-387 Reduced 0.86%	44,473 $1.94 Million
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $41,477 - $49,219	1,031 Added 2.35%	44,860 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $82,931 - $96,646	2,133 Added 5.12%	43,829 $1.93 Million
Q3 2021 Dec 08, 2021	BUY	$38.79 - $43.16 $677,855 - $754,220	17,475 Added 72.15%	41,696 $1.6 Million
Q3 2021 Nov 05, 2021	SELL	$38.79 - $43.16 $646,318 - $719,131	-16,662 Reduced 40.76%	24,221 $1.11 Million
Q2 2021 Aug 10, 2021	BUY	$36.52 - $41.46 $243,588 - $276,538	6,670 Added 19.5%	40,883 $1.63 Million
Q1 2021 May 12, 2021	SELL	$34.27 - $40.01 $45,921 - $53,613	-1,340 Reduced 3.77%	34,213 $1.23 Million
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $67,390 - $79,001	-1,978 Reduced 5.27%	35,553 $1.31 Million
Q3 2020 Nov 09, 2020	BUY	$38.11 - $42.99 $35,442 - $39,980	930 Added 2.54%	37,531 $1.41 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $160,038 - $184,169	4,226 Added 13.05%	36,601 $1.48 Million
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $217,224 - $326,672	-6,690 Reduced 17.13%	32,375 $1.23 Million
Q4 2019 Jan 28, 2020	SELL	$42.0 - $48.25 $30,282 - $34,788	-721 Reduced 1.81%	39,065 $1.83 Million
Q3 2019 Oct 22, 2019	BUY	$40.46 - $43.52 $32,772 - $35,251	810 Added 2.08%	39,786 $1.7 Million
Q2 2019 Jul 18, 2019	BUY	$39.4 - $42.7 $2,994 - $3,245	76 Added 0.2%	38,976 $1.56 Million
Q1 2019 May 06, 2019	SELL	$38.57 - $42.69 $1.5 Million - $1.66 Million	-38,900 Reduced 50.0%	38,900 $1.62 Million
Q1 2019 May 01, 2019	BUY	$38.57 - $42.69 $1.44 Million - $1.59 Million	37,211 Added 91.68%	77,800 $3.24 Million
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $188,659 - $213,065	-4,991 Reduced 10.95%	40,589 $1.56 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $17,092 - $18,356	-430 Reduced 0.93%	45,580 $1.82 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $12,397 - $13,383	-313 Reduced 0.68%	46,010 $1.84 Million
Q1 2018 May 18, 2018	BUY	$36.18 - $40.15 $503,878 - $559,169	13,927 Added 42.99%	46,323 $1.81 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $321,770 - $381,499	-9,105 Reduced 21.94%	32,396 $1.16 Million
Q3 2017 Nov 16, 2017	SELL	$39.44 - $41.55 $85,111 - $89,664	-2,158 Reduced 4.94%	41,501 $1.67 Million
Q2 2017 Aug 15, 2017	BUY	N/A	43,659	43,659 $1.9 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account